|
Re: Quote from a January 19, 2021 review
|
6
|
Resverlogix Corp.
|
Jan 21, 2021 03:46PM
|
|
BET bromodomain suppression inhibits vascular inflammation by blocking NF-κB and
|
6
|
Resverlogix Corp.
|
Oct 27, 2016 04:32PM
|
|
Re: Enrollment
|
6
|
Resverlogix Corp.
|
Aug 22, 2016 02:52PM
|
|
Re: Bear
|
5
|
Resverlogix Corp.
|
Jul 19, 2020 11:28AM
|
|
Re: When in Rome.......
|
5
|
Resverlogix Corp.
|
Aug 27, 2016 04:15PM
|
|
All - I mean ALL - about the ASSURE trial
|
5
|
Resverlogix Corp.
|
Sep 15, 2017 03:19PM
|
|
REPROGRAM - trial with RVX208.
|
5
|
Resverlogix Corp.
|
Jul 13, 2020 04:23PM
|
|
mCRPC and BET inhibitors
|
5
|
Zenith Epigenetics
|
Jan 26, 2016 03:28PM
|
|
Re: Is this relevant to RVX
|
5
|
Resverlogix Corp.
|
May 17, 2020 11:21AM
|
|
Re: This week could be very telling....
|
5
|
Resverlogix Corp.
|
Sep 25, 2016 06:08AM
|
|
Re: From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
5
|
Resverlogix Corp.
|
Oct 21, 2020 02:28PM
|
|
Re: HL
|
5
|
Resverlogix Corp.
|
Nov 17, 2017 03:34PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
5
|
Resverlogix Corp.
|
Sep 01, 2021 12:26PM
|
|
Re: Last pull back we bounced off the 12 DMA....
|
5
|
Resverlogix Corp.
|
Oct 11, 2016 12:57PM
|
|
Re: Technicals have looked good before....
|
5
|
Resverlogix Corp.
|
Sep 01, 2016 03:41PM
|
|
Re: I'll keep my opinions
|
4
|
Resverlogix Corp.
|
Sep 12, 2016 03:51PM
|
|
Re: BETonMACE Cognition Sub-Study Published
|
4
|
Resverlogix Corp.
|
Sep 03, 2021 02:37PM
|
|
Re: Entresto Trial (Novartis)
|
4
|
Resverlogix Corp.
|
Jun 24, 2020 02:47AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
4
|
Resverlogix Corp.
|
Dec 16, 2021 02:17PM
|
|
Re: New patent application - USA Inventor
|
4
|
Resverlogix Corp.
|
May 08, 2017 03:51PM
|
